These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 35197264)

  • 1. EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update.
    Landewé RBM; Kroon FPB; Alunno A; Najm A; Bijlsma JW; Burmester GR; Caporali R; Combe B; Conway R; Curtis JR; Elkayam O; Gossec L; Heijstek MW; Haupt L; Iagnocco A; Isaacs JD; Juhász IÁ; Makri S; Mariette X; McInnes IB; Mehta P; Mueller-Ladner U; Schulze-Koops H; Smolen JS; Wiek D; Winthrop KL; Navarro-Compán V; Machado PM
    Ann Rheum Dis; 2022 Dec; 81(12):1628-1639. PubMed ID: 35197264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk and prognosis of SARS-CoV-2 infection and vaccination against SARS-CoV-2 in rheumatic and musculoskeletal diseases: a systematic literature review to inform EULAR recommendations.
    Kroon FPB; Najm A; Alunno A; Schoones JW; Landewé RBM; Machado PM; Navarro-Compán V
    Ann Rheum Dis; 2022 Mar; 81(3):422-432. PubMed ID: 34876462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry.
    Machado PM; Lawson-Tovey S; Strangfeld A; Mateus EF; Hyrich KL; Gossec L; Carmona L; Rodrigues A; Raffeiner B; Duarte C; Hachulla E; Veillard E; Strakova E; Burmester GR; Yardımcı GK; Gomez-Puerta JA; Zepa J; Kearsley-Fleet L; Trefond L; Cunha M; Mosca M; Cornalba M; Soubrier M; Roux N; Brocq O; Durez P; Conway R; Goulenok T; Bijlsma JW; McInnes IB; Mariette X
    Ann Rheum Dis; 2022 May; 81(5):695-709. PubMed ID: 34972811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2.
    Landewé RB; Machado PM; Kroon F; Bijlsma HW; Burmester GR; Carmona L; Combe B; Galli M; Gossec L; Iagnocco A; Isaacs JD; Mariette X; McInnes I; Mueller-Ladner U; Openshaw P; Smolen JS; Stamm TA; Wiek D; Schulze-Koops H
    Ann Rheum Dis; 2020 Jul; 79(7):851-858. PubMed ID: 32503854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correspondence on "Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry" by Machado
    Bourguiba R; Delplanque M; Savey L; Hentgen V; Grateau G; Georgin-Lavialle S;
    Ann Rheum Dis; 2023 Dec; 82(12):e228. PubMed ID: 35817471
    [No Abstract]   [Full Text] [Related]  

  • 6. SARS-CoV-2 vaccine safety in adolescents with inflammatory rheumatic and musculoskeletal diseases and adults with juvenile idiopathic arthritis: data from the EULAR COVAX physician-reported registry.
    Lawson-Tovey S; Machado PM; Strangfeld A; Mateus E; Gossec L; Carmona L; Raffeiner B; Bulina I; Clemente D; Zepa J; Rodrigues AM; Mariette X; Hyrich KL;
    RMD Open; 2022 Jul; 8(2):. PubMed ID: 35908834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations for COVID-19 vaccination in people with rheumatic disease: Developed by the Singapore Chapter of Rheumatologists.
    Santosa A; Xu C; Arkachaisri T; Kong KO; Lateef A; Lee TH; Leong KH; Low AHL; Sriranganathan MK; Tan TC; Teng GG; Thong BY; Fong W; Lahiri M
    Int J Rheum Dis; 2021 Jun; 24(6):746-757. PubMed ID: 33973379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19: autoimmunity, multisystemic inflammation and autoimmune rheumatic patients.
    Szekanecz Z; Balog A; Constantin T; Czirják L; Géher P; Kovács L; Kumánovics G; Nagy G; Rákóczi É; Szamosi S; Szűcs G; Vályi-Nagy I
    Expert Rev Mol Med; 2022 Mar; 24():e13. PubMed ID: 35311631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 2.
    Curtis JR; Johnson SR; Anthony DD; Arasaratnam RJ; Baden LR; Bass AR; Calabrese C; Gravallese EM; Harpaz R; Kroger A; Sadun RE; Turner AS; Williams EA; Mikuls TR
    Arthritis Rheumatol; 2021 Aug; 73(8):e30-e45. PubMed ID: 34128356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features of patients with rheumatic and musculoskeletal diseases during the coronavirus disease 2019 pandemic and the association of its relapse with infection: Across-sectional study.
    Zhang Y; Xu P; Huang J; Hu Z
    Int J Rheum Dis; 2024 Apr; 27(4):e15150. PubMed ID: 38661306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases.
    Furer V; Rondaan C; Heijstek MW; Agmon-Levin N; van Assen S; Bijl M; Breedveld FC; D'Amelio R; Dougados M; Kapetanovic MC; van Laar JM; de Thurah A; Landewé RB; Molto A; Müller-Ladner U; Schreiber K; Smolar L; Walker J; Warnatz K; Wulffraat NM; Elkayam O
    Ann Rheum Dis; 2020 Jan; 79(1):39-52. PubMed ID: 31413005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological response to SARS-CoV-2 vaccination in patients with inflammatory rheumatic disease treated with disease modifying anti-rheumatic drugs: A cohort study and a meta-analysis.
    Auroux M; Laurent B; Coste B; Massy E; Mercier A; Durieu I; Confavreux CB; Lega JC; Mainbourg S; Coury F
    Joint Bone Spine; 2022 Oct; 89(5):105380. PubMed ID: 35490940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases.
    Boyarsky BJ; Ruddy JA; Connolly CM; Ou MT; Werbel WA; Garonzik-Wang JM; Segev DL; Paik JJ
    Ann Rheum Dis; 2021 Aug; 80(8):1098-1099. PubMed ID: 33757968
    [No Abstract]   [Full Text] [Related]  

  • 14. Response to: 'Correspondence on 'Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries' by Nokhatha
    Dejaco C; Bijlsma JW; Buttgereit F
    Ann Rheum Dis; 2021 Oct; 80(10):e171. PubMed ID: 33509796
    [No Abstract]   [Full Text] [Related]  

  • 15. 2021 EULAR points to consider to support people with rheumatic and musculoskeletal diseases to participate in healthy and sustainable paid work.
    Boonen A; Webers C; Butink M; Barten B; Betteridge N; Black DC; Bremander A; Boteva B; Brzezińska O; Chauhan L; Copsey S; Guimarães V; Gignac M; Glaysher J; Green F; Hoving JL; Marques ML; Smucrova H; Stamm TA; Wiek D; Wilkie R; Woolf AD; Burmester GR; Bijlsma JW; Verstappen SMM
    Ann Rheum Dis; 2023 Jan; 82(1):57-64. PubMed ID: 36109139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of third-dose SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal disease.
    Connolly CM; Frey S; Chiang TP; Teles M; Alejo JL; Albayda J; Shah AA; Werbel WA; Segev DL; Christopher-Stine L; Paik JJ
    Rheumatology (Oxford); 2022 Oct; 61(10):e302-e304. PubMed ID: 35583259
    [No Abstract]   [Full Text] [Related]  

  • 17. Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in times of SARS-CoV-2-methodology, key messages and justifying information.
    Schulze-Koops H; Krüger K; Hoyer BF; Leipe J; Iking-Konert C; Specker C;
    Rheumatology (Oxford); 2021 May; 60(5):2128-2133. PubMed ID: 33502500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EULAR 2021 updated viewpoints on SARS-CoV-2 vaccination in patients with RMDs: a guidance to answer patients' questions.
    Bijlsma JW;
    Ann Rheum Dis; 2022 Jun; 81(6):786-788. PubMed ID: 35121591
    [No Abstract]   [Full Text] [Related]  

  • 19. Correspondence on 'Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries'.
    Al Nokhatha S; MacEoin N; Conway R
    Ann Rheum Dis; 2021 Oct; 80(10):e170. PubMed ID: 33509797
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety of the first dose of mRNA SARS-CoV-2 vaccines in patients with rheumatic and musculoskeletal diseases.
    Connolly CM; Ruddy JA; Boyarsky BJ; Avery RK; Werbel WA; Segev DL; Garonzik-Wang J; Paik JJ
    Ann Rheum Dis; 2021 Aug; 80(8):1100-1101. PubMed ID: 33741555
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.